Vedachalam Srikanth, Cook Schuyler, Koppert Tanner, Okabe Toshimasa, Weiss Raul, Afzal Muhammad R
Division of Cardiovascular Medicine, Wexner Medical Center, Ohio State University Medical Center, Columbus, OH, USA.
Department of Internal Medicine, Adena Regional Medical Center, Chillicothe, OH, USA.
J Innov Card Rhythm Manag. 2020 May 15;11(5):4100-4105. doi: 10.19102/icrm.2020.110504. eCollection 2020 May.
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is the latest option among devices clinically available for the prevention of sudden cardiac death, with experience from previous trials and postmarketing studies supporting the feasibility and safety of this kind of system. The extracardiac positioning of the S-ICD obviates the need for transvenous leads, which translates into lower incidence rates of lead-related complications and systemic infections. This review will highlight the results of pertinent studies related to the perioperative management of S-ICDs and review potential approaches to minimizing the risk of complications such as hematoma at the pulse generator location, unsuccessful defibrillation due to suboptimal S-ICD lead and generator positioning, and postoperative pain. An extensive literature search using PubMed was conducted to identify relevant articles.
皮下植入式心脏复律除颤器(S-ICD)是临床上可用于预防心脏性猝死的最新设备,先前试验和上市后研究的经验支持了这种系统的可行性和安全性。S-ICD的心外定位避免了经静脉导线的使用,这意味着与导线相关的并发症和全身感染的发生率更低。本综述将重点介绍与S-ICD围手术期管理相关的相关研究结果,并探讨将诸如脉冲发生器部位血肿、S-ICD导线和发生器定位欠佳导致除颤失败以及术后疼痛等并发症风险降至最低的潜在方法。通过使用PubMed进行广泛的文献检索以识别相关文章。